Telemedically Assisted Sampling of COVID-19 Patients - Is the Sampling Quality Sufficient
Telemedicine, Pharynx, COVID-19
About this trial
This is an interventional diagnostic trial for Telemedicine focused on measuring Telemedicine, supervised testing, nasopharyngeal swab,, COVID-19, rapid diagnostic tests
Eligibility Criteria
Inclusion Criteria:
- Written informed consent
- Patients visiting the test-station for a SARS-CoV-2 test
- Consent to comply with the study protocol
- Age of 18 or older
Exclusion Criteria:
- Refusal to comply with the study protocol
- Digital illiteracy (i.e. patients who would never use telemedicine as they do not feel competent enough to use the necessary tools)
- Not German or English speaking
- People trained in the use of rapid diagnostic tests (HCP, biologists) will be excluded to reduce bias
Sites / Locations
- Teststation Praxis Dr. med Bielecki
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
telemedically assisted guided oropharyngeal + nasal (OP+N) self-sampling (GSS): OP+N GSS
unsupervised OP+N self-sampling (USS): OP+N USS
After performing the telemedically assisted OP+N GSS procedure, the patients will continue to be sampled by HCP OP+N and HCP NP.
Written instructions on how to perform a self-test will be provided, representing the instructions that come along with a commercially available rapid test set. An instructional online video tutorial or similar would also account as the latest state of the art.30 However, this has not yet been implemented comprehensively with all available test sets. After performing the OP+N USS procedure, the patients will continue to be sampled by HCP OP+N and HCP NP.